Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives

E-ISSN： 2212-3938|3|3|166-173

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.3, Iss.3, 2008-09, pp. : 166-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation

By Szekeres Thomas Haushofer Alexander

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 163-168

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications

By Mayo Clara Bertran-Alamillo Jordi Molina-Vila Miguel Ángel Giménez-Capitán Ana Costa Carlota Rosell Rafael

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 789-802

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

By Innocenti Federico Ratain Mark J

Pharmacogenomics, Vol. 7, Iss. 8, 2006-12 ,pp. : 1211-1221

Future Medicine

Access to resources Recommend Favorite

Toxicity of sorafenib: clinical and molecular aspects

By Blanchet Benoit Billemont Bertrand Barete Stéphane Garrigue Hélène Cabanes Laure Coriat Romain Francès Camille Knebelmann Bertrand Goldwasser François

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 275-287

Informa Healthcare

Access to resources Recommend Favorite

Cyclosporin: An Updated Review of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral) in Organ Transplantation

By Dunn C.J. Wagstaff A.J. Perry C.M. Plosker G.L. Goa K.L.

Drugs, Vol. 61, Iss. 13, 2001-01 ,pp. : 1957-2016

Adis International

Access to resources Recommend Favorite